Perceptions and measurements of physical activity in patients with systemic lupus erythematosus.
Lupus., Mar;20(3):231-42 (2011)
Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2RÎ³-/- mice: a promising model for studying human disease.
Arthritis Rheum., Sep;63(9):2764-73 (2011)
Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
Ann. Rheum. Dis., Oct;69(10):1827-30 (2010)
Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Arthritis Rheum., Jan;63(1):212-8 (2011)
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.
Arthritis Rheum., Jun;62(6):1718-22 (2010)
Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.
Lupus., May;18(6):530-8 (2009)
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction.
Arthritis Rheum., Jan;60(1):22-9 (2009)
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Am. J. Med., Oct;121(10 Suppl 1):S3-8 (2008)
Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation.
Trans. Am. Clin. Climatol. Assoc., 118:99-114 (2007)
Pathogenic role of antiphospholipid antibodies.
Lupus., May;17(5):405-11 (2008)
Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
Arthritis Rheum., Feb;58(2):384-8 (2008)
Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a.
Clin. Immunol., Apr;127(1):56-65 (2008)
Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation.
J. Reprod. Immunol., Jan;77(1):51-6 (2008)
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
Arthritis Rheum., Oct;56(10):3412-9 (2007)
Cardiovascular manifestations of rheumatologic diseases.
Circulation., Nov;116(20):2346-55 (2007)
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
J. Exp. Med., Sep;203(9):2165-75 (2006)
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Arthritis Rheum., Dec;54(12):3918-25 (2006)
Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.
Am. J. Obstet. Gynecol., Feb;196(2):167.e1-5 (2007)
Autoantibody selection and production in early human life.
J. Clin. Invest., Mar;117(3):598-601 (2007)
Systemic lupus erythematosus predicts increased left ventricular mass.
Circulation., Jul;116(4):419-26 (2007)